On Friday, Roivant Sciences Ltd (NASDAQ: ROIV) was 1.49% up from the session before settling in for the closing price of $11.38. A 52-week range for ROIV has been $8.73 – $13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -99.51%. When this article was written, the company’s average yearly earnings per share was at -399.82%. With a float of $401.30 million, this company’s outstanding shares have now reached $695.94 million.
Let’s determine the extent of company efficiency that accounts for 750 employees. In terms of profitability, gross margin is 92.05%, operating margin of -1340.3%, and the pretax margin is -776.7%.
Roivant Sciences Ltd (ROIV) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Roivant Sciences Ltd stocks. The insider ownership of Roivant Sciences Ltd is 40.97%, while institutional ownership is 65.54%. The most recent insider transaction that took place on Jul 21 ’25, was worth 1,152,000. In this transaction President & Immunovant CEO of this company sold 100,000 shares at a rate of $11.52, taking the stock ownership to the 1,462,223 shares. Before that another transaction happened on Jul 21 ’25, when Company’s Officer proposed sale 100,000 for $11.52, making the entire transaction worth $1,151,942.
Roivant Sciences Ltd (ROIV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -399.82% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
You can see what Roivant Sciences Ltd (ROIV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 33.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 103.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Looking closely at Roivant Sciences Ltd (NASDAQ: ROIV), its last 5-days average volume was 4.39 million, which is a drop from its year-to-date volume of 5.96 million. As of the previous 9 days, the stock’s Stochastic %D was 29.65%.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 91.41%, which indicates a significant increase from 78.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.21, while its 200-day Moving Average is $11.18. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $11.68. Second resistance stands at $11.81. The third major resistance level sits at $11.98. If the price goes on to break the first support level at $11.39, it is likely to go to the next support level at $11.22. Should the price break the second support level, the third support level stands at $11.09.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are 679,806K outstanding shares of the company, which has a market capitalization of 7.85 billion. As of now, sales total 29,050 K while income totals -171,980 K. Its latest quarter income was 9,020 K while its last quarter net income were 169,380 K.
